GLP-1 receptor agonists are known to lower inflammation throughout the body, enhance insulin sensitivity, and promote weight loss -- all factors that can influence cancer growth and progression
Muscle tissue is highly vascularized
The efficacy of OZEMPIC was compared with placebo, sitagliptin, exenatide extended-release (ER), and insulin glargine
People with diabetes are more prone to yeast infections, so those using semaglutide for diabetes management may have a higher baseline risk compared to those using it strictly for weight loss
Comparison of the decrease in glycated hemoglobin levels of diabetic patients caused by a 40-week treatment with tirzepatide (5, 10 or 15 mg/wk) or semaglutide (1 mg/wk)
Pause or stop whenever you need to